The Efficacy and Safety of TAS-102(Suyuan) Combined With Bevacizumab as First-line Therapy in Patients With Advanced Colorectal Cancer
Clinical trial NCT06092242 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06092242
- Sponsor
- The Second Affiliated Hospital of Shandong First Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-15
- Primary completion
- 2025-10-15
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.